Personalized prediction for a 49 year old woman who takes Saloop, Prednisone, Pentasa, Allopurinol, Pantoprazole, Asacol, Imuran (an AI-powered real world drug study)

Summary:

This is a personalized prediction of potential side effects and undetected conditions for up to one year, if you would have adverse effects. The study is created by eHealthMe based on data from the FDA.

What are the drugs?

Saloop has active ingredients of salep. eHealthMe is studying from 7 Saloop users. Check the latest studies of Saloop.
Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 636,805 Prednisone users. Check the latest studies of Prednisone.
Pentasa has active ingredients of mesalamine. It is often used in crohn's disease. eHealthMe is studying from 23,324 Pentasa users. Check the latest studies of Pentasa.
Allopurinol has active ingredients of allopurinol. It is often used in gout. eHealthMe is studying from 190,836 Allopurinol users. Check the latest studies of Allopurinol.
Pantoprazole has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 285,126 Pantoprazole users. Check the latest studies of Pantoprazole.
Asacol has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 20,618 Asacol users. Check the latest studies of Asacol.
Imuran has active ingredients of azathioprine. It is often used in crohn's disease. eHealthMe is studying from 34,914 Imuran users. Check the latest studies of Imuran.

What are the conditions?

Gerd (gastro-oesophageal reflux disease) is found to be associated with 3,426 drugs and 3,419 conditions by eHealthMe. Check the latest studies of Gerd.
Colitis ulcerative (inflammation of colon with ulcer) is found to be associated with 2,164 drugs and 2,026 conditions by eHealthMe. Check the latest studies of Colitis ulcerative.

Potential side effects:

Abdominal pain

9.31% for females aged 49 (±5) who have colitis ulcerative

Acute kidney failure

6.02% for females aged 49 (±5) who have gerd

Breast cancer

6.65% for females aged 49 (±5) who have colitis ulcerative and gerd

Chronic kidney disease

8.02% for females aged 49 (±5) who have colitis ulcerative and gerd

Diarrhea

6.56% for females aged 49 (±5) who have colitis ulcerative and gerd

Drug ineffective

6.22% for females aged 49 (±5) who take pentasa
6.22% for females aged 49 (±5) who take allopurinol
6.22% for females aged 49 (±5) who take pantoprazole
6.22% for females aged 49 (±5) who take saloop
6.22% for females aged 49 (±5) who take asacol
6.22% for females aged 49 (±5) who take imuran
6.22% for females aged 49 (±5) who take prednisone
6.08% for females aged 49 (±5) who have colitis ulcerative and gerd

Fatigue

6.42% for females aged 49 (±5) who take saloop
6.42% for females aged 49 (±5) who take allopurinol
6.42% for females aged 49 (±5) who take pantoprazole
6.42% for females aged 49 (±5) who take asacol
6.42% for females aged 49 (±5) who take imuran
6.42% for females aged 49 (±5) who take prednisone
6.42% for females aged 49 (±5) who take pentasa
5.26% for females aged 49 (±5) who have colitis ulcerative and gerd

Gastroesophageal reflux disease

5.26% for females aged 49 (±5) who have gerd

Haematochezia

9.44% for females aged 49 (±5) who have colitis ulcerative

Headache

5.76% for females aged 49 (±5) who take pentasa
5.76% for females aged 49 (±5) who take allopurinol
5.76% for females aged 49 (±5) who take pantoprazole
5.76% for females aged 49 (±5) who take asacol
5.76% for females aged 49 (±5) who take imuran
5.76% for females aged 49 (±5) who take saloop
5.76% for females aged 49 (±5) who take prednisone
5.14% for females aged 49 (±5) who have colitis ulcerative and gerd

Joint pain

7.3% for females aged 49 (±5) who have colitis ulcerative

Malaise

5.15% for females aged 49 (±5) who have colitis ulcerative

Nausea

6.56% for females aged 49 (±5) who take saloop
6.56% for females aged 49 (±5) who take allopurinol
6.56% for females aged 49 (±5) who take pantoprazole
6.56% for females aged 49 (±5) who take asacol
6.56% for females aged 49 (±5) who take imuran
6.56% for females aged 49 (±5) who take prednisone
6.56% for females aged 49 (±5) who take pentasa
5.13% for females aged 49 (±5) who have colitis ulcerative and gerd

Pain

5.45% for females aged 49 (±5) who have colitis ulcerative

Ulcerative colitis

5.72% for females aged 49 (±5) who have colitis ulcerative and gerd

Potential co-existing conditions:

Abdominal discomfort

7.33% for females aged 49 (±5) who have colitis ulcerative and gerd

Depression

8.86% for females aged 49 (±5) who have colitis ulcerative and gerd

Diabetes

5.68% for females aged 49 (±5) who have gerd

High blood cholesterol

7.37% for females aged 49 (±5) who have colitis ulcerative and gerd

High blood pressure

10.9% for females aged 49 (±5) who have colitis ulcerative and gerd

Hyperchlorhydria

5.02% for females aged 49 (±5) who have gerd

Indigestion

23.65% for females aged 49 (±5) who have colitis ulcerative and gerd

Multiple sclerosis

9.06% for females aged 49 (±5) who take saloop
9.06% for females aged 49 (±5) who take prednisone
9.06% for females aged 49 (±5) who take pentasa
9.06% for females aged 49 (±5) who take allopurinol
9.06% for females aged 49 (±5) who take pantoprazole
9.06% for females aged 49 (±5) who take asacol
9.06% for females aged 49 (±5) who take imuran

Pain

10.24% for females aged 49 (±5) who have colitis ulcerative and gerd

Stress and anxiety

6.77% for females aged 49 (±5) who have colitis ulcerative and gerd

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used, and more. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

Related publications that referenced our studies

Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
Almarshad HA, "Effect of ginger rhizome extract on lymphocytopenic guinea pig with azathioprine", African Journal of Pharmacy and Pharmacology, 2014 Nov .

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.